American Century Companies Inc. Buys 53,221 Shares of Nature's Sunshine Products, Inc. (NASDAQ:NATR)

American Century Companies Inc. increased its position in shares of Nature's Sunshine Products, Inc. (NASDAQ:NATR - Free Report) by 25.7% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 260,479 shares of the company's stock after acquiring an additional 53,221 shares during the quarter. American Century Companies Inc. owned 1.39% of Nature's Sunshine Products worth $3,925,000 as of its most recent SEC filing.

Several other hedge funds have also made changes to their positions in the company. Wasatch Advisors LP acquired a new stake in Nature's Sunshine Products during the 4th quarter worth about $7,430,000. Skylands Capital LLC lifted its position in shares of Nature's Sunshine Products by 722.1% in the second quarter. Skylands Capital LLC now owns 333,101 shares of the company's stock worth $5,020,000 after purchasing an additional 292,581 shares in the last quarter. Hillsdale Investment Management Inc. increased its stake in shares of Nature's Sunshine Products by 8.2% in the first quarter. Hillsdale Investment Management Inc. now owns 215,030 shares of the company's stock worth $4,466,000 after acquiring an additional 16,300 shares during the last quarter. Bailard Inc. purchased a new stake in shares of Nature's Sunshine Products during the second quarter worth $197,000. Finally, Trexquant Investment LP acquired a new stake in Nature's Sunshine Products during the fourth quarter valued at $217,000. Hedge funds and other institutional investors own 79.40% of the company's stock.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on NATR. Canaccord Genuity Group started coverage on Nature's Sunshine Products in a research report on Friday, September 13th. They issued a "buy" rating and a $18.00 target price on the stock. StockNews.com upgraded shares of Nature's Sunshine Products from a "buy" rating to a "strong-buy" rating in a research note on Tuesday, September 10th. Canaccord Genuity Group assumed coverage on shares of Nature's Sunshine Products in a research note on Friday, September 13th. They set a "buy" rating and a $18.00 price target on the stock. Finally, DA Davidson reduced their price objective on shares of Nature's Sunshine Products from $23.00 to $21.00 and set a "buy" rating for the company in a research note on Monday, August 12th.

Nature's Sunshine Products Price Performance

NATR traded up $0.52 on Friday, hitting $14.04. The company had a trading volume of 25,598 shares, compared to its average volume of 56,103. The stock has a market cap of $262.97 million, a price-to-earnings ratio of 15.91 and a beta of 0.87. The company's fifty day moving average price is $14.13 and its 200 day moving average price is $16.11. Nature's Sunshine Products, Inc. has a 1-year low of $10.81 and a 1-year high of $21.72.

Nature's Sunshine Products (NASDAQ:NATR - Get Free Report) last issued its quarterly earnings data on Thursday, August 8th. The company reported $0.07 earnings per share for the quarter, missing analysts' consensus estimates of $0.25 by ($0.18). The firm had revenue of $110.55 million during the quarter. Nature's Sunshine Products had a return on equity of 9.79% and a net margin of 3.50%.

Nature's Sunshine Products Company Profile

Nature's Sunshine Products, Inc, a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision.